← Leaderboards
Michael J Borowitz
Johns Hopkins University
$4,928,476
Attributed
$6,435,373
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–10$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$6,435,373 · 4
By mechanism
R01$4,158,632 · 1
RC2$1,708,950 · 1
R21$567,791 · 1
P50$0 · 1
Top collaborators
- Meenakshi Devidas2 shared
- Julie M Gastier-Foster2 shared
- Stephen Patrick Hunger2 shared
- Mignon Lee-Cheun Loh2 shared
- Charles G. Mullighan2 shared
- Cheryl L Willman2 shared
- Brent L Wood2 shared
- Gregory H Reaman1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Richard J Jones$17,555,212
- Ben H Park$14,510,999
- Anirban Maitra$50,247,714
- Patrick A Brown$1,041,781
- Chetan Bettegowda$9,213,403
Others in their field
Top investigators on “Flow Cytometry”
- Peter Gordon Gillespie · Oregon Health And Science University$107,304,619
- Joseph E Robertson · Oregon Health & Science University$60,681,954
- Prasant Mohapatra · University Of California At Davis$53,606,662
- David Heimbrook · Leidos Biomedical Research, Inc.$44,124,630
- Roger Detels · University Of California Los Angeles$40,925,678
- Simon J. Atkinson · University Of California At Davis$35,573,802
Research focus
Flow CytometryPediatric Neoplasm /CancerGrantRelapseNeoplasm /Cancer Relapse /RecurrenceNewly DiagnosedLesionNeoplasm /Cancer DiagnosisLeukemia, Lymphocytic, AcuteLeukemia, Lymphocytic, Acute, L1Acute Lymphocytic LeukemiaEnrollmentBaseGeneticPrognosticChildChildren&AposLaboratoriesClinical ResearchDiagnosis Design /EvaluationDiagnosisCohortRelative (Related Person)Response
Grant awards (15)
Targeted Therapies for Childhood Acute Lymphoblastic Leukemia$876,194
RC2 · FY2010 · CA
Minimal Residual Disease in Pediatric ALL in Relation to Other Prognostic Factors$262,609
R01 · FY2010 · CA · contact PI
Targeted Therapies for Childhood Acute Lymphoblastic Leukemia$832,756
RC2 · FY2009 · CA
Minimal Residual Disease in Pediatric ALL in Relation to Other Prognostic Factors$561,044
R01 · FY2009 · CA · contact PI
Minimal Residual Disease in Pediatric ALL in Relation to Other Prognostic Factors$546,364
R01 · FY2008 · CA · contact PI
Minimal Residual Disease in Pediatric ALL in Relation to Other Prognostic Factors$542,666
R01 · FY2007 · CA · contact PI
Minimal Residual Disease in Pediatric ALL in Relation to Other Prognostic Factors$605,565
R01 · FY2006 · CA · contact PI
Minimal Residual Disease in Childhood ALL in Relapse$279,891
R21 · FY2006 · CA · contact PI
Minimal Residual Disease in Childhood ALL in Relapse$287,900
R21 · FY2005 · CA
RESIDUAL DISEASE DETECTION IN ALL USING FLOW CYTOMETRY$180,676
R01 · FY2004 · CA
RESIDUAL DISEASE DETECTION IN ALL USING FLOW CYTOMETRY$207,853
R01 · FY2003 · CA
RESIDUAL DISEASE DETECTION IN ALL USING FLOW CYTOMETRY$410,724
R01 · FY2002 · CA
Core--Human specimen resource and laboratory$0
P50 · FY2002 · CA
RESIDUAL DISEASE DETECTION IN ALL USING FLOW CYTOMETRY$402,122
R01 · FY2001 · CA
RESIDUAL DISEASE DETECTION IN ALL USING FLOW CYTOMETRY$439,009
R01 · FY2000 · CA